ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
Myeloma
ecancer
New Classification for Identifying High-Risk Myeloma Based on Cytogenetic Abnormalities
FEATURING
Jill Corre
- 2 views
- December 31, 2024
ecancer
MILESTONE Trial: Guiding Transplant Decisions in NDMM With MRD
FEATURING
Susan Bal
- 2 views
- December 30, 2024
ecancer
Approaches to Risk Stratification in Smoldering Myeloma
FEATURING
Irene Ghobrial
- 5 views
- December 30, 2024
ecancer
Isa-KRd in NDMM: Takeaways From the MIDAS & CONCEPT Studies
FEATURING
Philippe Moreau
- 7 views
- November 18, 2024
ecancer
Frailty Subanalysis of IMROZ: Isatuximab + RVD for Transplant-Ineligible NDMM Patients
FEATURING
Salomon Manier
- 11 views
- November 12, 2024
ecancer
Idecabtagene Vicleucel for R/R MM: Updated Results From the KarMMa Trial
FEATURING
Larry Anderson
- 60 views
- October 21, 2021
ecancer
Efficacy and Safety Data for Ciltacabtagene Autoleucel in Progressive Multiple Myeloma: CARTITUDE-2 Trial Updates
FEATURING
Adam D. Cohen
- 126 views
- October 21, 2021
ecancer
Melflufen and Dexamethasone vs. Pomalidomide and Dexamethasone in R/R MM: Results of the OCEAN Trial
FEATURING
Fredrik Schjesvold
- 50 views
- October 21, 2021
ecancer
EHA 2021 Highlights on KRd for Lenalidomide-Refractory MM
FEATURING
Claudio Cerchione
- 92 views
- September 2, 2021
- 1
ecancer
EHA 2021 Update on Carfilzomib Non-refractory MM: Surveying Efficacy Data of Once Weekly XKd
FEATURING
Cristina Gasparetto
- 66 views
- September 2, 2021
ecancer
EHA 2021 Update on D-Rd vs. Rd in Transplant-Ineligible Newly Diagnosed MM: MAIA Study
FEATURING
Thierry Facon
- 19 views
- September 2, 2021
